Our in vivo model utilized the humanized transgenic NSG expressing hu-IL-15 with a mature NK cell population (Fig. 5a–e) and demonstrated a significant restriction of tumor growth only with the introduction of the LV/hu-IL-12 transduced sarcoma (Fig. 5). This evidence concerns the gene IL15 and sarcoma.